XENiOS® Will Seek Regulatory Approval for i-lung®

XENiOS®, a commercial-stage medical device company, announced today it expects to receive CE-marking for its i-lung® device within 18 months. XENIOS expects to launch i-lung® in 2017. Currently available devices lack durability and wearability. Additionally, the size of current systems restricts patient mobility and limits quality of life. i-lung represents an innovative and first-of-its-kind fully wearable artificial lung for long-term use in a hospital environment.

"The availability of i-lung will open the door to significant medical progress for respiratory support. For many patients in lung failure currently undergoing invasive mechanical ventilation, the use of i-lung is designed to avoid sedation and immobility, thus creating active, self-managed patients," said Georg Matheis, MD, Managing Director & Founder of XENIOS. "In addition, i-lung is designed to be used to bridge the waiting time for a donor organ (bridge-to-lung-transplant)."

"Of special note," added Juergen Boehm, MD, Managing Director of Xenios, "i-lung paves the way for XENiOS to continue development of a bioartificial lung for use by patients outside of a hospital environment analogous to current artificial heart protocols, which will represent a paradigm shift in the approach to long-term respiratory support."

i-lung is the result of the successful completion of the AmbuLung project, a three-year R&D consortium project funded by the European Union’s FP7 Program that developed the basis for i-lung, the world’s first-of-its-kind wearable artificial lung. In addition to XENiOS, the consortium included Fraunhofer IGB (Stuttgart, Germany); Imperial College of Science, Technology and Medicine (London, UK); and, the University of Florence (Italy).

"We are forever indebted to the vision and the work of Professor Dame Julia Polak, who passed away last year," said Dr. Matheis. "Julia and I co-founded the i-lung project, and because of her enormous contribution i-lung is now a reality, and a bioartificial next-gen of i-lung on the horizon." The author of some 1,000 original papers, 115 review articles and editor or author of 25 books, Julia Polak, MD, PhD, was one of the most widely cited researchers in her field, and had undergone a heart lung transplant. She served on several national and international tissue engineering and stem cell advisory panels, and was the European editor of the journal Tissue Engineering.

Funding for the commercialization of i-LUNG® has already been procured. XENIOS announced in September 2015 that it received an eight-figures cash infusion from existing investors, in part to fund CE-marking and launch of i-LUNG, led by ZFHN, one of the largest Single Family Offices in Germany investing in start-up companies.

About XENiOS®
XENiOS AG is a privately held medical technology company that is comprised of two product brands, novalung® and i–cor®, that run on a single XENiOS® console. The XENIOS platform is designed to provide at least four essential advantages with its minimally invasive lung and heart therapies: (1) patients are awake and mobile;(2) self-actuated patients facilitate improved outcomes; (3) there is no ventilator-associated lung injury or pneumonia; (4) additionally, the XENIOS platform maintains a physiologic natural pulse designed to protect the heart.

Most Popular Now

EyeFocus Eye Care Innovation Conference

31 January 2017, London, UK. EyeFocus is holding a one day conference about eye-care innovation to end the second EyeFocus program. The conference is instead of the traditional demo day, and...

Read more

New Virtual Reality Technology may Impro…

A combination of traditional physical therapy and technology may improve the motor skills and mobility of an impaired hand by having its partner, more mobile hand lead by example through...

Read more

European Commission Seeks Input on a Ref…

Smart wearables provide technology-based solutions to pressing societal and economic challenges in the areas of healthy ageing, elderly care, emergency management, safety at work, productivity enhancement, training of professionals, energy...

Read more

Top 20 eHealth News of 2016

Look back at the most prominent moments from the year 2016. We are proud to announce the 20 most popular eHealth News from 2016, the most commonly viewed news articles...

Read more

conhIT Newcomer Awards 2017: Health IT I…

25 - 27 April 2017, Berlin, Germany. By bringing representatives of the Health IT industry and other Healthcare institutions together with prospective young employees conhIT 2017, Europe's leading event for Health...

Read more

Philips and Leading Network of Healthcar…

Royal Philips (NYSE: PHG, AEX: PHIA) today announced the signing of a 10-year strategic partnership agreement with the Expert Group of Companies, one of Russia's leading network of healthcare centers...

Read more

Ireland's First Babies Born with an Elec…

The HSE and eHealth Ireland are delighted to announce the arrival of Emily, one of Ireland’s first newborns to have their own electronic health record from birth. Weighing 7lb 5oz...

Read more

MSD Innovation Factory: SMART STOCK Chal…

Pharmacy Chains in the EEMEA Region are growing rapidly. These are in the range of 150+ pharmacy outlets or so called PoS (Point of Sale). Thousands of prescriptions are being...

Read more

Dudley Group Adds Allscripts SunriseTM E…

In the fourth quarter of 2016, The Dudley Group NHS Foundation Trust selected Allscripts (NASDAQ:MDRX) fully integrated health IT solution to help achieve its objective to become a fully digital...

Read more

Philips Highlights Cloud-Based Innovatio…

Royal Philips (NYSE: PHG, AEX: PHIA) is showcasing innovative connected health products and solutions that empower consumers to become ever-more engaged in their health. Leveraging Philips' expertise in the consumer...

Read more

MSD Innovation Factory: INNOREP Challeng…

Nowadays, pharmaceutical launches are becoming harder and more competitive. In some cases, MSD products are neither the only nor the first player in the market. Besides, clinical data can be...

Read more

MSD Innovation Factory: EDU CARE Challen…

At healthcare professionals' waiting room around the globe there is a repeated scenario: inattentive patients spend their time before being seen by their healthcare professionals. Sometimes playing with their smartphones...

Read more
(HEALTH IT) SPACE - Take a look at who has just Joined